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Abstract 
Motivation: The extraordinary genetic and antigenic variabil-
ity of RNA viruses is arguably the greatest challenge to the 
development of broadly effective vaccines. No single viral 
variant can induce sufficiently broad immunity, and incor-
porating all known naturally circulating variants into one 
multivalent vaccine is not feasible. Further, no objective 
strategies currently exist to select actual viral variants that 
should be included or excluded in polyvalent vaccines. 
Results: To address this problem, we demonstrate a method 
based upon graph theory that quantifies the relative im-
portance of viral variants. We demonstrate our method 
through application to the envelope glycoprotein gene of a 
particularly diverse RNA virus of pigs: porcine reproductive 
and respiratory syndrome virus (PRRSV). Using distance ma-
trices derived from sequence nucleotide difference, amino 
acid difference, and evolutionary distance we constructed 
viral networks and used common network statistics to as-
sign each sequence an objective ranking of relative “im-
portance.” To validate our approach, we use an indepen-
dent published algorithm to score our top-ranked wild-type 
variants for coverage of putative T-cell epitopes across the 
9383 sequences in our dataset. Top-ranked viruses achieve 
significantly higher coverage than lower-ranked viruses, and 
top-ranked viruses achieve nearly equal coverage as a syn-
thetic mosaic protein constructed in silico from the same 
set of 9383 sequences. 
Conclusion: Our approach relies on the network structure 
of PRRSV, but applies to any diverse RNA virus because it 
identifies subsets of viral variants that are the most impor-
tant to overall viral diversity. We suggest that this method, 
through the objective quantification of variant importance, 
provides criteria for choosing viral variants for further char-
acterization, diagnostics, surveillance, and ultimately poly-
valent vaccine development. 
1 Introduction 
Of all infectious threats to global health, viruses with 
RNA genomes have proven to be the most difficult to control 
(Cleaveland et al., 2001; Jones et al., 2008). Viruses such as HIV, 
influenza virus, hepatitis C virus, and Dengue virus, have de-
fied control in part as a result of their extraordinary genetic and 
antigenic variation (Katze et al., 2008), and their consequent 
ability to evolve rapidly (Belshaw et al., 2008; Domingo, 2002; 
Drake and Holland, 1999; Holmes, 2009). HIV, for example, can 
evolve into diverse strains within an individual patient over the 
course of days or weeks, confounding the development of vac-
cines and antivirals and frustrating diagnostics and surveillance 
(Crandall, 1999; Gaschen et al., 2002). Thus, the efficacy of even 
the most immunogenic vaccines is questionable in a field set-
ting where multiple variants may circulate simultaneously, and 
where novel variants are continuously evolving. Vaccine stud-
ies almost universally acknowledge this challenge but have yet 
to develop objective criteria selecting vaccine candidates that 
adequately, yet parsimoniously, capture overall viral diversity 
(Barouch, 2008; Korber et al., 2009). 
In an effort to develop vaccines that maximize the repre-
sentation of antigenic features present in diverse viral popula-
tions, a series of computational strategies have been proposed. 
Driven largely by HIV vaccine research, the approaches have 
included concatenating commonly recognized T-cell epit-
opes (Palker et al., 1989), creating pseudoprotein strings of T-
cell epitopes (De Groot et al., 2005), and generating consensus 
overlapping peptide sets from proteins (Thomson et al., 2005). 
Evolutionary approaches such as the use of consensus se-
quences (Gao et al., 2004; Gao et al., 2005; Gaschen et al., 2002), 
and the most recent common ancestor (MRCA) of viral pop-
ulations, have also been proposed with the assumption that 
these approaches capture viral diversity (Gaschen et al., 2002). 
Unfortunately, experimental studies in animal models using 
these strategies have documented underwhelming humoral 
immune responses (Doria-Rose et al., 2005; Gao et al., 2005).   
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The most widely studied approach uses a genetic algorithm 
to generate, select, and recombine (in silico) potential T-cell 
epitopes into full-length “mosaic” protein sequences that can 
provide greater coverage of global viral variants than could 
any single wild-type protein (Fischer et al., 2007). This mosaic 
protein approach was able to achieve between 74% and 87% 
coverage of HIV-1 Gag sequences, compared to only between 
37% and 67% using a single natural Gag protein (Fischer et al., 
2007). Subsequent experimental studies have demonstrated 
that these computationally designed vaccines augment the 
breadth and depth of antigen-specific T-cell responses as com-
pared with consensus or natural sequence HIV-1 antigens (Ba-
rouch et al., 2010; Santra et al., 2010). However, this approach 
yields synthetic peptides with unknown biological properties 
that may not be able to be incorporated into a recombinant 
live vaccine. 
Given the need for an objective strategy to select wild-type 
viral variants that might be adapted for polyvalent vaccines, 
we propose a method based on network analysis. In recent 
years, interest in the analysis and modeling of networks has 
surged outside the traditional fields of social science (Wasser-
man and Faust, 1994; Watts, 2004), mathematics and computer 
science (Albert and Barabasi, 2002; Butts, 2009). Network sta-
tistics have proven to be powerful tools for studying diverse 
phenomena such as social interactions, connections amongst 
neurons, and the structure of the Internet, and for optimizing 
solutions to engineering problems (Albert and Barabasi, 2002; 
Watts, 2004). For our purpose, it has long been recognized that 
biological molecules interact directly and indirectly (Yamada 
and Bork, 2009), and network statistics have proven fruitful in 
drug discovery studies (Azmi et al., 2010; Zhao and Li, 2010), 
human disease classification (Barabasi et al., 2011; Loscalzo et 
al., 2007), and in functional analyses of gene regulatory net-
works (Yu et al., 2007). As such, it is possible to construct viral 
networks that explicitly define the positional importance of in-
dividual viral variants in the network based on relationships 
between biomolecules (e.g. Allesina and Pascual, 2008; Salathe 
et al., 2010; Yamada and Bork, 2009). 
In the present paper, we use a highly diverse and particu-
larly problematic RNA virus of pigs as a case study: porcine 
reproductive and respiratory syndrome virus (PRRSV). This 
exercise provides “proof of concept,” as well as a novel strat-
egy for the control of this virus of critical importance to agri-
culture. We present a detailed topological network analysis 
that considers the importance of every individual viral vari-
ant i by considering every possible interaction (direct and in-
direct) between variant i and j. We use network indices, from 
local to global, including node degree, a series of centrality 
indices and PageRank, the algorithm at the heart of Google. 
We then examine how these indices relate to each other, and 
discuss how to choose the most appropriate metric for select-
ing viral variants for study, and to help guide the develop-
ment of polyvalent vaccines, diagnostic testing strategies, 
and epidemiological surveillance. Our study makes minimal 
initial assumptions about evolutionary processes or viral bi-
ology and can complement other approaches such as the mo-
saic protein approach (Fischer et al., 2007) to polyvalent vac-
cine design. 
2 Methods 
2.1 Porcine reproductive and respiratory syndrome 
virus 
Porcine reproductive and respiratory syndrome virus (PRRSV) is 
the causative agent of porcine reproductive and respiratory syndrome 
(PRRS), an economically damaging disease of domestic swine (Tian et 
al., 2007; Zimmerman et al., 1997). PRRSV is in the order Nidovirales, 
family Arteriviridae, along with equine arteritis virus, lactate dehydro-
genase elevating virus, and simian hemorrhagic fever virus (Conzel-
mann et al., 1993; Meulenberg et al., 1993). The virus has a short (ap-
proximately 15 kb) single stranded, positive-sense RNA genome that 
encodes at least nine open reading frames (ORFs) (Conzelmann et al., 
1993; Meulenberg et al., 1993). Despite significant research, including a 
focus on the virus’s genetic diversity, it has remained difficult to con-
trol (Shi et al., 2010; Shi et al., 2010). Vaccination, in particular, has vari-
able efficacy and has failed to reduce transmission or to reduce clini-
cal signs (see Thanawongnuwech and Suradhat, 2010 and references 
therein). 
One likely cause for the difficulty in controlling PRRSV is its ge-
netic and antigenic variability. Type 1 PRRSV (or European origin) 
differs at approximately 50% of nucleic acid positions from Type 2 
PRRSV (of North American origin), implying a high degree of diver-
gence between continents (Forsberg et al., 2001; Forsberg et al., 2002; 
Murtaugh et al., 2010). Further, within these viral types, PRRSV ex-
ists as a spectrum of genotypes, displaying considerable heteroge-
neity with very little geographic population substructure (Shi et al., 
2010; Stadejek et al., 2006). Additionally, PRRSV varies between farms, 
herds, among animals within herds, and even within individual an-
imals (Goldberg et al., 2000; Goldberg et al., 2003). Extensive nucleo-
tide sequence data are available for the viral ORF5 gene, which is used 
commonly for phylogenetic analyses and source tracking (e.g. Shi et 
al., 2010). Consequently, ORF5 diversity acts as a marker of PRRSV 
variability. 
2.2 Creation of a core PRRSV sequence dataset 
All PRRSV ORF5 sequences from isolates in Genbank, the National 
Center for Biotechnology Information’s on-line sequence repository 
( http://www.ncbi.nlm.nih.gov/genbank/ ), and the now defunct 
PRRSV Database were downloaded in December 2010 (see Supple-
mentary Material for sequence files). These sequences were comprised 
of 25,265 worldwide samples, three live-attenuated vaccine strains 
(MLV, ATP, and PrimePac), and one laboratory attenuated strain 
(Abst-1). Most viruses were from the United States of America, but vi-
ruses from Canada, Mexico, China, Korea, Japan, Thailand, Austria, 
Denmark, Italy and Poland were also present. 
As a first “cleaning” step to ensure we only included wild-type 
variants, we removed sequences that were described with any of the 
following terms: patent, vaccine, attenuated, attenuation, clone. The 
remaining sequences were then aligned using default settings in MUS-
CLE v3.6 (Edgar, 2004), with manual correction in Mesquite (Maddi-
son and Maddison, 2009). At the same time, we removed all type 1 
variants, thus restricting our analyses to type 2 PRRSV. The remaining 
aligned sequences underwent a redundancy analysis within the com-
puter program Mothur (Schloss et al., 2009), and identical sequences 
were removed. In addition, to avoid bias in subsequent network and 
phylogenetic analyses (Lemmon et al., 2009), we removed sequences 
with any nucleotide base ambiguities. The next filtering step was to re-
move poor quality data using three criteria: first, sequences were re-
moved if they did not have a start and a stop codon; second, sequences 
were removed if more than 1% of the gene sequence was missing; and 
third, a sequence was removed if it produced an insertion or dele-
tion in the alignment that was biologically implausible (e.g. causing 
a frame shift and introducing premature stop codons) or occurred in 
fewer than 0.005% of sequences. The alignment was then screened 
for evidence of recombination using 3Seq (Boni et al., 2010; Boni et al., 
2007), with all putative recombinants subject to secondary screening 
and validation using RDP3 (Martin et al., 2010): if identified by three 
or more methods within the software, sequences were removed from 
rA n k i n g v i r us es f o r r A ti o n A l p o l y v A le n t v A c c i n e d e v e lo p me n t   3
further analysis. For reference, even though some were eliminated in 
our filtering process, we included several common reference strains: 
VR2332, RespPRRS, China “atypical,” JA-142, MN-184, PrimePac, and 
ATP viral variants. This process resulted in a set of 9383 non-identical 
ORF5 sequences that represent the full extent of known genetic diver-
sity of wildtype type 2 PRRSV.  
 2.3 Construction of PRRSV networks 
We constructed three undirected, unweighted networks using ad-
jacency matrices derived from 1) nucleotide sequence differences, 2) 
amino acid sequence differences, and 3) evolutionary distances. We 
generated the nucleotide difference adjacency matrix using PAUP* 
4.0 (Swofford, 2003), with cells containing values representing uncor-
rected numbers of nucleotide differences between pairs of aligned se-
quences. Similarly, we generated a second adjacency matrix by cal-
culating the uncorrected number of changes between amino acid 
sequences using program R (Team, 2010) with the APE (Paradis, et 
al., 2004) and SeqinR packages (Charif and Lobry, 2007). Our third 
adjacency matrix represented evolutionary distances. Values in cells 
were patristic distances (distances along the branches of a phyloge-
netic tree) calculated by PAUP* 4.0 (Swofford, 2003): we built the phy-
logeny used to calculate these distances using RAxML 7.2.8 (Stamata-
kis, 2006; Stamatakis et al., 2008) maximum likelihood analyses on the 
CIPRES Science Gateway (Miller et al., 2010). We implemented a Gen-
eral-Time-Reversible nucleotide substitution model with 4 categories 
of gamma distributed rate heterogeneity and a proportion of invariant 
sites (GTR + г + I) model of molecular evolution. 
The three matrices represent different types of biological relation-
ships among viral sequences. The first makes the fewest assumption 
about the structure or function of each variant, the second acknowl-
edges that immunological cross-protection and virulence operate at 
the level of proteins, and the third acknowledges that evolutionary 
history might be an important constraint on viral immunobiology. Al-
though these matrices contain quantitative information on relation-
ships between viral variants, to simplify theory and measurement, we 
dichotomized each using the sna package in R (Butts, 2008). This ap-
proach is appropriate given that the relationship under study, in this 
instance genetic distance, is stable and the values taken across pairs 
are constrained (Butts, 2009). 
2.4 Topological indices used to describe positional 
importance 
To rank sequences, we used a range of indices that are dependent 
on the characteristics of the focal node but also include information 
about the overall topology of the viral network. 
The most fundamental metric, the degree (or connectivity; k) of a 
sequence, describes the number of links a sequence makes with other 
sequences. Those sequences with high degrees are those that are con-
nected highly with all other sequences. This index is useful for identi-
fying viral variants that have the most direct connections to other vari-
ants. Other, secondary, clustering techniques further detail the relative 
importance of each sequence to “sequence diversity space” and in-
clude: closeness; betweenness; eigenvector centrality; and PageRank. 
Closeness provides a measure that describes the position, in terms 
of distance, from a focal sequence to all other sequences and is mea-
sured as: 
(1) 
Intuitively, closeness provides an index of the extent to which a given 
sequence has short paths to all other sequences. This is a measure of 
whether a sequence is in the “middle” of our defined sequence space; 
smaller values can be interpreted to indicate sequences of greater im-
portance (i.e. the removal of such a sequence will affect a majority of 
other sequences). 
Betweenness, first introduced by Freeman (Freeman, 1977), is a 
measure that describes the centrality of a sequence, provided as a fre-
quency with which a sequence is located on the shortest path between 
all other sequences. First, let δst (v) denote the pairwise dependency, or 
the fraction of shortest paths between s and t that pass through v. Fol-
lowing this, the betweenness of virus v is defined as:  
Table 1. Network ranking of select porcine reproductive and respiratory syndrome virus reference sequences and the top 5 ranked sequences out 
of 9383. 
                                                         Nucleotide network                              Amino acid network                    Evolutionary distance network 
 k CC B w PR  k CC B w PR  k CC B w PR 
Reference variants: 
VR-2332 (PRU87392) 2564 1991 2845 3423 3361 3121 2650 2951 2714 3439 4099 1524 727 4163 3625 
RespPRRS (AF066183) 3915 2857 4478 4279 4875 5665 4627 5447 3814 5624 5406 2807 1520 4441 4989 
JA-142 (AY424271) 595 571 530 780 554 31 39 91 79 31 445 511 743 485 534 
MN-184 (EF488739) 3605 4619 1881 6497 1367 3352 4303 4484 6080 3097 3107 1259 997 6327 1459 
PrimePac (AF066384) 586 489 533 701 583 202 221 206 468 133 136 136 46 482 94 
China “atypical” (EF112446) 2732 1909 3387 2467 4248 5322 4120 3153 3295 5317 1448 2354 2866 1447 1911 
Top 5 ranked variants1: 
DQ475317 1 1 5 1 1 12 12 59 4 11 3 3 6 1 4 
DQ477864 2 2 26 2 2 16 13 81 7 15 10 10 26 6 15 
PRU66382 6 6 75 4 11 20 20 138 11 19 4 4 10 2 5 
DQ477862 25 22 174 18 33 21 21 141 12 21 7 7 16 4 10 
AB175723 24 20 147 16 28 25 24 149 17 26 5 5 3 3 7 
Ranking statistics include degree (k), closeness centrality (CC), betweenness (B), eigenvector centrality (w), and PageRank (PR). Variants are referred 
to using common name or GenBank accession numbers: rankings are on a scale of 1 to 9383. 
1. The top 5 sequences are a selection of those variants that were found ranked in the top 100 in all three networks using degree (k) as the rank-
ing metric.  
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 (2) 
Conceptually, high-betweenness sequences lie on a large number 
of nonredundant shortest paths between other vertices; they may be 
thought of as “bridges.” This metric has been used to assess node im-
portance in other biological networks (Yamada and Bork, 2009), to de-
scribe sexual contact networks (Liljeros et al., 2001), and to describe the 
structure of the worldwide air transportation network (Guimera et al., 
2005). 
Eigenvector centrality, as described by Bonacich (Bonacich, 1972), 
determines node scores that correspond to the leading eigenvector of 
the sequence adjacency matrix. These scores arise from a reciprocal 
process in which the centrality of each sequence is proportional to the 
sum of the centralities of those sequences to which it is connected. The 
defining equation is: 
λw = Aw                                                (3) 
where A is the adjacency matrix of the graph, lambda is the constant 
(the eigenvalue), and w is the eigenvector. In general, sequences that 
have high eigenvector centralities are those that are connected to 
many other sequences that are, in turn, connected to many others. 
This metric has been widely used to identify key network compo-
nents, including connectivity within the human brain (Lohmann et 
al., 2010). 
PageRank, in the context in which we use it, rates viral variants 
as important if they receive links from other viruses that are in turn 
also rated as important. Each virus i is assigned an importance, and 
each link aij (exiting virus i to enter virus j) carries an equal frac-
tion of the importance value: the importance of the virus is then the 
sum of the importance assigned to its incoming connections. This re-
cursive problem is solved by building a matrix S in which each ele-
ment represents the fraction of importance assigned to a link: sub-
sequently, importance is solved by computing the eigenvector 
associated with the dominant eigenvalue of the matrix (Bryan and 
Leise, 2006). 
Finally, we analyze the community structure of the networks by 
computing the modularity Q given by (Clauset et al., 2004): 
 (4) 
where m is the number of modules inside the network, eii is the frac-
tion of links in the network connecting nodes of the same commu-
nity i, and ai is the fraction of links that have one or two ends inside 
community i. The larger the fraction of links inside each community, 
the higher the value of Q. In this way, modularity Q can be taken 
as a reference parameter in order to find the optimal community di-
visions based upon the topology of the network. These algorithms 
have been used extensively to address interaction patterns within 
varied systems, including but not limited to American football (Gir-
van and Newman, 2002), and plant-pollinator dynamics (Olesen et 
al., 2007). 
The critical concept to note in the above analytical approach is that 
the position a sequence takes within “sequence diversity space” is de-
termined by its similarity to other sequences, and the similarity values 
of the other sequences to which it is connected. In using these algo-
rithms, we account for the underlying structure of the genetic relation-
ships between sequences and can objectively rank each sequence and 
its contribution to PRRSV genetic diversity. 
2.5 Relationship between indices 
We calculated the indices described above for every individual vi-
ral variant in each PRRSV network. We ranked the importance of all 
variants according to their values of a particular index. Thus, in to-
tal there were 5 rankings corresponding to 5 different indices (i.e., k, 
CC, B, w, PR) for each of three networks. We also examined whether or 
not different indices provided the same information about the relative 















































indices, we conducted hierarchical clustering on the rankings of the 
viral variants by the values of the 5 indices: first, we standardized the 
values within indices, and then we used similarity measures appro-
priate for interval data. Second, we used Kendall rank correlations be-
tween all pairs of indices; and third, we applied a Kendall Concor-
dance test to determine whether the observed ranks were significantly 
different from those expected by chance when independently ranking 
9383 nodes by 5 indices.  
2.6 Design and evaluation of T-cell vaccine candidates 
We compared the putative epitope coverage of known PRRSV 
variants by generating vaccine “mosaic” proteins using a promising 
design algorithm from the HIV literature (Fischer et al., 2007). To as-
sess whether high-ranking variants achieved better epitope coverage 
than low-ranking variants, we used the Vaccine Epitope Coverage 
Assessment online tool (Epicover; Thurmond et al., 2008) to compute 
how well the top and bottom ranked proteins from each network cov-
ered putative epitopes across the full dataset of 9383 wild-type PRRSV 
sequences. To further explore the association between network rank-
ing and epitope coverage, we ranked sequences according to each 
centrality metric, selected every 20th ranked sequence and calculated 
its epitope coverage. We quantified the strength of association using 
MIC (Reshef et al., 2011), and Pearson’s correlation coefficient (ρ). To 
Figure 1. Hierarchical clustering dendrogram showing the similarities 
between rankings of nodes by the 5 network indices. The indices in-
clude, degree (k), closeness centrality (CC), betweenness (B), eigenvec-
tor centrality (w), and PageRank (PR), and measure various aspects of 
the relative importance of viral variants. We show clustering of rank-
ings based upon the network derived from nucleotide differences (A), 
amino acid difference (B), and evolutionary distance (C).   
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compare our method to the mosaic protein approach (Thurmond et 
al., 2008), we used the Mosaic Vaccine Designer online tool to gener-
ate in silico a single mosaic protein from the 9383 wild-type sequences. 
We then used Epicover to measure the coverage of this single mosaic 
across the 9383 wild-type sequences. 
3 Results 
The viral network derived from nucleotide differences in-
cluded 9383 variants, and had 88,040,689 potential links of 
which 11,044,560 were realized, resulting in a connectance of 
0.125. The amino acid derived network included 7889 vari-
ants, and had 62,236,321 potential links of which 8,636,124 
were realized, resulting in a connectance of 0.139. The remain-
ing network, derived from evolutionary distances, included 
9383 viral variants with 11,005,086 realized links, with a resul-
tant value of connectance of 0.125. Measured in this way, con-
nectance is the average fraction of viral variants to which an 
individual variant in the network is connected, based upon 
similarity. Twenty-two viral variants were ranked in the top 
100 sequences in all three networks, and 51 variants were 
ranked in the bottom 100 sequences in all three networks. 
All three viral networks displayed cumulative degree dis-
tributions that were different from what would be expected 
if the link distribution were random. Each network had data 
consistent with an exponential degree distribution (P(k) ~ 
exp(-γk): nucleotide AICc = –8449.9; evolutionary distance 
AICc = –7637.8; amino acid AICc = –6191.2). The data were 
not well represented by the power-law (P(k) ~ k–γ: nucleotide 
AICc = –1246.5; evolutionary distance AICc = –1417.4; amino 
acid AICc = –816.1), or truncated power-law (P(k) ~ k–γ exp(–
k/kx): nucleotide AICc = –8171.8; evolutionary distance AICc = 
–1410.9; amino acid AICc = – 5847.8). The identity of the best-
fit model is secondary to our data departing from a power-law 
distribution; this suggests that very highly connected variants 
are more rare than would be expected if the networks were 
built using a scale-free distribution to describe the number of 
interactions per virus. 
There were differences in the rankings of viral variants by 
the five different indices (for select sequence rankings, see Ta-
ble 1). Qualitatively, there were differences in the information 
provided by the indices rankings of variants based upon the 
hierarchical clustering dendrograms (Figure 1). These dendro-
grams were insensitive to the clustering method. The more 
similar indices are in their ranking of the variants, the shorter 
the distance between the branch representing them, and the 
first shared branching point. Nevertheless, the rank orderings 
of variants were statistically significantly correlated between 
indices (i.e., a variant ranked highly by degree (k) tended also 
to receive a high ranking as measured by eigenvector central-
ity; Table 2). This was further validated using Kendall’s W, 
which showed that the ranking provided by each index is sig-
nificantly similar across each viral network: nucleotide differ-
ences (W = 0.82, χ2 = 38421, P < 0.01); amino acid differences 
(W = 0.85, χ2 = 33495, P < 0.01); and evolutionary distance (W = 
0.798, χ2 = 37447, P < 0.01). 
Our ranking approach identified a single wild-type se-
quence that achieved coverage of putative epitopes essentially 
equal to that of a “mosaic” protein generated using all 9383 se-
quences (Figure 2). Our top ranked variant (DQ475317) within 
the nucleotide network achieved 48.5% coverage, whereas the 

































covered more putative epitopes than those that were ranked 
poorly: the top ranking amino acid variant achieved 40% cov-
erage; and the most important variant in the evolutionary dis-
tance network achieved 41% coverage (Figure 2). The 22 vari-
ants ranked in the top 100 of all three networks achieved, on 
average, 43% (± 1.7% standard deviation) coverage of putative 
epitopes derived from known PRRSV ORF5 variants. By con-
trast, the 51 variants ranked in the bottom 100 of all three net-
works achieved, on average, only 26% (± 3.5% standard devi-
ation). This difference was statistically significant (t = 28.20; 69 
degrees of freedom; P < 0.0001). There was a significant (P < 
0.0001) relationship between network ranking and putative 
epitope coverage when variants were ranked by: degree (Fig-
ure 3: ρ = −0.76; MIC = 0.63); closeness (ρ =−0.78; MIC = 0.61); 
betweenness (ρ = −0.66; MIC = 0.52); PageRank (ρ = −0.65; 
MIC = 0.47); and eigenvector centrality (ρ = −0.59; MIC = 0.53). 
 
4 Discussion 
Our results demonstrate that a dataset of 9383 sequences 
could be ranked according to three matrices and five network 
centrality metrics. Using interaction networks derived from 
sequence nucleotide difference, amino acid difference, and 
evolutionary distance we were able to score individual PRRSV 
sequences based on their relative importance to the viral net-
work. This yielded 22 sequences that were represented in the 
top 100 sequences in all matrices, and provided objective cri-
teria for selecting viral variants for polyvalent vaccine design. 
We identified a single wild-type sequence that covered 48% of 
Table 2. Kendall rank correlation coefficients, t, between the rank or-
dering by the 5 indices of the 9383 nodes in the porcine reproductive 
and respiratory syndrome virus network. 
  k     CC  B  w  PR 
Nucleotide  k  1.0000  0.7084  0.5974  0.7273  0.7339 
CC   1.000  0.6655  0.6719  0.5633 
B    1.0000  0.4531  0.6993 
w     1.0000  0.4690 
 PR      1.0000 
  k     CC  B  w  PR 
Amino acid  k  1.0000  0.8151  0.6348  0. 5876  0. 9427 
 CC   1.0000  0. 7139  0. 6589  0. 7872 
 B    1.0000  0. 5005  0. 6464 
 w     1.0000  0. 5342 
 PR      1.0000 
  k     CC  B  w  PR 
Evolutionary  k  1.0000  0.6656  0.5719  0.6224  0.8268 
 CC   1.0000  0.7552  0.5612  0.6957 
 B    1.0000  0.4087  0.6571 
 w     1.0000  0.4576 
 PR      1.0000 
Correlation coefficients for the nucleotide derived network (Nucleo-
tide), amino acid similarity network (Amino acid), and evolutionary 
distance network (Evolutionary). 
All correlations were significant at P < 0.01 level.  
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putative epitopes derived from the known diversity of PRRSV. 
Further, we document a relationship between our ranked vari-
ants and putative epitope coverage. In summary, we have 
demonstrated that it is possible to use network statistics to 
rank viruses with respect to their overall “importance” within 
a network, and that the resulting rankings can help guide the 
selection of viruses for inclusion in vaccines. 
The key insight provided by our work is that it is possible 
to construct de novo a virus network from sequence data and 
objectively quantify the positional importance of viral variants 
within such a network. For vaccine development, it is clear 
that choosing a single variant as a type-strain is problematic, 
and vaccination with all known viral variants is not techni-
cally feasible. Consequently, there is need for techniques that 
“filter” highly diverse genomic datasets, and select represen-
tative sequences for further study. We suggest that the calcula-
tion of network indices that describe the relative importance of 
viral variants may inform decisions about type-strain selection 
and polyvalent vaccine development. Though this approach 
is flexible, and can be implemented using small and less di-
verse genomic data, more traditional approaches may be 
more appropriate in these situations. Of the indices we mea-
sured, eigenvector centrality provided a robust prediction of 
variant importance. This metric provides a measure of a viral 
variant’s global position, rather than its sheer number of con-
nections (i.e., k), and describes sequences that are highly con-
nected and fall within densely populated substructures of the 
viral network. More generally, our case study of the PRRSV 
system serves as an illustration of the potential of these tech-
niques in the objective selection of important viral variants for 
additional study. 
We demonstrate that it is possible to select only highly 
ranked sequences and achieve equal or better coverage of pu-
tative T-cell epitopes than using low ranked sequences, and 
that top-ranked sequences achieve nearly as good T-cell epi-
tope coverage as artificial mosaic proteins derived computa-
tionally from the full set or sequences. The latter conclusion 
is important because mosaic proteins derived from the afore-
mentioned algorithm may, when synthesized, have biological 
properties that render them unsuitable for inclusion in actual 
vaccines (Fischer et al., 2007; Nickle et al., 2007; Rolland et al., 
2007). Our method achieves nearly equal coverage by identi-
fying the “most important” wild-type viruses. These viruses, 
if they can be found in reference collections, would make ex-
cellent candidates for subsequent biological studies, with the 
goal of modifying their immunomodulatory properties and 
virulence to the point that they would be suitable vaccine can-
didates. Our results predict that such vaccines would be bio-
logically viable while also conferring broadly cross-protective 
immunity. 
Our approach is likely to be useful given the extraordi-
narily large amounts of data currently available as a result of 
next-generation sequencing technologies (Holmes and Gren-
fell, 2009). Although existing computational methods to ac-
count for viral diversity are powerful when investigating 
small numbers of sequences, the size of potential tree-space 
and computational complexity increases faster than expo-
nentially with the number of sequences (Holmes and Gren-
fell, 2009; Rambaut et al., 2008). This forces use of biology-in-
dependent filters (e.g. limiting analysis to geographic regions, 
considering ease-of-access to samples, or using well charac-
terized genes) to produce a dataset that is manageable. At the 
Figure 2. Overall coverage of T-cell epitopes by vaccine candidates. 
Coverage of nine-mers in porcine reproductive and respiratory virus 
using either the top-ranked (left bar) or bottom-ranked (right bar) viral 
variant using degree (k) as the ranking metric. Exact (gray-shaded), and 
8 of 9 (one-off; white-shaded) coverage was computed for four test sit-
uations: a) the top- and bottom-ranked sequences from the nucleotide 
difference network; b) the top- and bottom-ranked sequences from 
the amino acid difference network; c) the top- and bottom-ranked se-
quences from the evolutionary distance network; and d) a mosaic pro-
tein generated from all 9383 sequences. The “mosaic” sequence was 
generated by the genetic algorithm described in (Fischer et al., 2007); 
all sequences, including the mosaic protein, were compared against all 
nine-mers generated from 9383 unique PRRSV variants. 
Figure 3. Association between network ranking and coverage of T-
cell epitopes. Coverage of nine-mers in porcine reproductive and re-
spiratory syndrome virus by a ranked subset of ORF5 viral variants. Vi-
ral variants were ranked using degree (k), derived from the nucleotide 
difference network. The putative epitope coverage of every 20th se-
quence was assessed using the Vaccine Epitope Coverage Assessment 
online tool (Thurmond et al., 2008).    
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other extreme, there is a growing recognition that the use of 
consensus sequences, though computationally efficient, may 
not capture the evolutionary dynamics or phenotypic vari-
ation necessary to generate immunogenetic and broadly ef-
fective vaccines (Aaskov et al., 2006; Wahala et al., 2010). Our 
approach provides a way of “distilling” this overwhelming di-
versity and focusing subsequent analyses on a small and ob-
jectively chosen subset of viral variants. Though biases may be 
introduced to the genetic networks due to limitations in source 
data, our approach is fully adaptable to sample sets with dif-
ferent or no biases, such as geographically restricted popula-
tions, or to virulent populations of viruses. Notably, our net-
work analyses were conducted and completed in 72 hours on 
a standard 2 GHz desktop computer with 8 GB of RAM. This 
suggests that our framework is not prohibitive from a compu-
tational perspective.  
We suggest that network centrality measures, in differen-
tiating viral variants according to how influential they are, 
can inform the selection of type-strains for vaccine design. 
The degree, k, of a node is the first indication of its central-
ity; intuitively a well-connected sequence with a high degree 
will be traversed by a proportionally larger number of short 
paths than those sequences with low degrees. However, it is 
important to distinguish this metric as a local index; it does 
not take in to account the importance of the neighboring 
nodes. This suggests that a variant, though well connected, 
may fall within a relatively sparse area of the network, and 
may not account for a large amount of genetic information. 
To overcome this restriction, the other centrality indices 
quantify positional importance using global measures ac-
counting for genetic distance (i.e., the number of edges on 
the shortest path connecting i and j). Eigenvector centrality 
is particularly useful; previous research has suggested that 
nodes characterized by higher eigenvector centrality play a 
more influential role in the structure and dynamics of the 
networks in which they are nested (Allesina and Pascual, 
2008; Allesina and Pascual, 2009). In our viral networks, 
those variants that have high eigenvector centrality scores 
are those that contribute disproportionately to global viral 
diversity, acting as core variants that are likely to prove use-
ful in the development of vaccines, diagnostic tests, and epi-
demiological surveillance strategies. 
Another potential metric that provides insight into variant 
selection is the betweenness of a sequence. One biological in-
terpretation of this index is that it quantifies the probability 
that node i represents an intermediate step in the evolution be-
tween one sequence to another. In Table 2, we demonstrated 
a positive correlation between sequence degree and sequence 
betweenness, confirming the intuitive idea that sequences of 
high degree are those with high betweenness: the larger the 
number of neighbors a particular sequence has, the greater the 
probability that the sequence will fall on a shortest path be-
tween other sequences. Deviations from this correlation in-
dicate “gatekeeper” sequences, i.e. sequences that represent 
unique pathways to subsections within the network. Thus, us-
ing this metric we are able to quantify a variant’s importance 
in two ways: firstly, a variant that has a high betweenness 
score provides a measure of the amount of genetic information 
which the variant controls; and secondly, if a variant falls out-
side of the correlation we document, it represents a unique se-
quence that acts as a bridge to distinct modules within the vi-
ral network. 
Our rankings of PRRSV reference variants reveal that many 
studies of PRRSV biology to date have focused on reference 
strains that are not central to the diversity of the virus. Typ-
ically, such reference strains are selected because of ease-of-
access, publication history, and evaluation of whether the 
variant represents a particular geographic location or biolog-
ical property (e.g. virulence, immunogenecity). Our analysis 
shows that selection of such strains may limit the generality 
of subsequent conclusions. Additionally, current phylogenetic 
methods that attempt to classify type-strains (Shi et al., 2010), 
though analytically rigorous, carry a series of assumptions 
that introduce biases into variant selection. This is particu-
larly true in PRRSV, where incomplete geographic sampling 
and a reliance on a gene for inference that is subject to strong 
immunological pressure has likely resulted in phylogenetic 
trees that are sub-optimal (Murtaugh et al., 2010). Given these 
weaknesses and the failings of current classification strate-
gies (see Murtaugh et al., 2010 and references therein), we sug-
gest that defining variant importance via network statistics is 
a promising and productive avenue. Indeed, this approach is 
best suited for PRRSV and other viruses with a large amount 
of genetic diversity and little phylogenetic substructure. In the 
case of viruses that sort into clear monophyletic clades, it may 
be impossible to select one variant that represents diversity 
across clades. In this situation, we suggest a ranking system 
based on specific scenarios, such as geographically restricted 
populations, virulent populations of viruses, or as in our case 
study, the selection of known subtypes. An alternate solution 
is to select sequences from within defined network groups us-
ing modularity-based clustering heuristics (see Newman, 2011 
and references therein). 
One strength of our approach is that it makes minimal as-
sumptions about viral biology in assigning the rankings of in-
dividual sequences. Underlying matrices of amino acid simi-
larity, for example, do not assign immunological importance 
to specific protein regions. However, our approach is very 
flexible for incorporating biological information as it is gen-
erated. For example, our approach could easily be applied to 
specific protein regions that future studies identify as being 
immunologically important. A weakness, however, is that the 
representational framework is restrictive given the dyadic na-
ture of interactions; if our goal is to develop an effective vac-
cine, this process may omit components of what is a complex 
system of interactions. Indeed, research in the HIV field has 
revealed that induction of protective immunity is a function 
of robust mucosal immunity, high avidity and polyfunctional 
T-cells, broad neutralizing antibodies and optimized vaccine 
delivery methods (Wijesundara et al., 2011). This is in addi-
tion to the difficulties associated with viral antigenic diver-
sity (Fischer et al., 2007). However, decades of research have 
been unsuccessful in the development of broadly effective vac-
cines for numerous highly variable pathogens. Thus, our ap-
proach to representing variability as a network, and ranking 
variants for further study, may prove to be a judicious strat-
egy that aids in the development of efficacious vaccines and 
targeted control. 
Important tasks for future studies include: (i) improving 
our knowledge of the biological meanings of different cen-
trality indices; (ii) extending and improving the ranking sys-
tem through comparative analyses of similar viruses; and (iii) 
testing whether the high ranking individual variants are bet-
ter in inducing cross-protective immunity than those with 
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lower rankings in vivo. Further, a potential and as yet unreal-
ized application of our approach is the targeted design of vac-
cines that modify virulence. Our case study incorporated all 
sequence variation, but it is possible to select for analysis only 
sequences of high virulence. Vaccines rarely provide full pro-
tection from disease, and those vaccines that are ineffective 
may unintentionally select for increased pathogen virulence 
(Gandon et al., 2001). We posit that, given the high likelihood 
that any vaccine against a highly variable RNA virus such as 
PRRSV would offer less-than-perfect protection, an alternative 
goal of vaccination could be to drive viral evolution intention-
ally towards benignness. Our ranking method could provide 
rational criteria for selecting among highly virulent types to 
include in vaccines that may, over time, drive the population 
of viruses towards lower virulence (Ewald, 2004). 
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Supplementary Information
The following three files in FASTA format are attached to the Download page:
1.  “prrsv_database.fasta” (10.4 Mb) contains all PRRSV sequences that were stored on http://prrsvdb.org prior to 
it closing.  See http://www.reeis.usda.gov/web/crisprojectpages/412855.html for description of database.
2.  “prrsv_from_genbank.fasta” (12.8 Mb) contains all PRRSV sequences that were stored on NCBI Genbank 
http://www.ncbi.nlm.nih.gov/genbank 
3.  “final_cleaned_prrsv_seqs.fasta” (%.9 Mb) is the final dataset used in network and phylogenetic analyses.  
These sequences were obtained in accordance with methods section 2.2.
